Influenza-associated excess respiratory mortality in China, 2010–15: a population-based studyLi Li, Hongjie Yu, Yunning Liu et al.|The Lancet Public Health|2019Cited by 317
Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trialXiaoqiang Liu, Jinzhong Lin, M M Zhao et al.|Human Vaccines & Immunotherapeutics|2025Cited by 1